Transparency Market Research E.coli Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022 Published Date 15-June-2015 110 Page Report Buy Now Request Sample Press Release E.coli Testing Market Expected to Reach USD 2.1 Billion in 2022 : Transparency Market Research Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com E.coli Testing Market REPORT DESCRIPTION E.coli Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022 According to a new market report published by Transparency Market Research “E.coli Testing Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022,” the global E.coli testing market was valued at USD 1.2 billion in 2013 and is estimated to reach USD 2.1 billion by 2022 at a CAGR of 6.58% from 2014 to 2022. Browse the full report at http://www.transparencymarketresearch.com/e-coli-testing-market.html Escherichia coli (E.coli) infections are common across all the parts of the world.The bacterium is known to cause frequent food- or water-borne and urinary tract infections. According to an article published in the Journal Emerging Infectious Diseases, E.coli accounts for over 85% of all urinary tract infections.Rapid development of drug resistance and their frequent outbreaks through contaminated food have raised serious health concerns.Epidemic of Shiga toxin producing E.coli strain O104:H4 in Germany was one the largest E.coli outbreaks.Therefore, the demand for rapid and accurate methods for detecting E.coli in clinical and environmental samples has increased considerably. Browse Press Release Of This Report:http://www.transparencymarketresearch.com/pressrelease/e-coli-testing-market.htm Browse Artical Of This Report:http://www.transparencymarketresearch.com/article/e-coli-testing-market.htm Environmental Protection Agency (EPA), U.S.has approved three methods for testing environmental water samples; these include membrane filtration, multiple tube fermentation or most probable number (MPN), and enzyme-substrate reaction based presence or absence (P/A) tests. MPN is one of the oldest method of E.coli enumeration, and is being replaced by membrane filtration method to a large extent. With membrane filtration method, large volume of water samples can be tested, and more accurate results can be provided as compared to multiple tube fermentation method. P/A tests are qualitative tests that produce colored substrate indicating presence of E.coli in water sample. P/A test is easy to perform, and does not require a skilled personnel. Further sophisticated laboratory equipment are not required for accurate test results; wherein only a small or medium size incubator is required to store test bottles. Due to these factors, P/A tests are rapidly capitalizing the E.coli testing market. Based on similar principal, the Transparency Market Research 2 E.coli Testing Market P/A tests have been modified to provide quantitative MPN count of E.coli in water sample. IDEXX Laboratories Colilert, Colisure, and Quanti-Tray are leading products in the market approved by the EPA. Various local players manufacture similar qualitative tests, however due to the absence of standard regulatory approvals, these tests do not contribute significantly to the overall market. Related & Recently Published Report by Transparency Market Research Platelet Rich Plasma Market : http://www.transparencymarketresearch.com/europe-platelet-rich-plasma-market.html From the point of view of test kits, P/A test kits account for majority of the volume sale; however, from the point of view of number of tests performed, membrane filtration method takes the lead.Key reason being majority of the membrane filtration tests are not performed using ready-to-use kits; individual laboratory apparatus are used to perform the tests.This trend is more evident in low- and middle-income countries, as this is a cost effective alternative to P/A test kits. Revenue wise enzyme-substrate tests account for 80% of the market share, while volume wise these tests account for 40% share. Get Sample Report Copy with TOC and Market Research : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4822 In 2013, Europe dominated the global E.coli testing market due to outbreak of foodborne infection in Germany in 2011 caused by Escherichia coli O104:H4 strain. In addition, rapidly growing bottled water industry also support the dominance of the region. The E.coli testing market in Asia Pacific was valued at USD 14.99 million in 2013 and is expanding at a CAGR of 6.92% from 2014 to 2022.Asia Pacific consists of the most promising economies such as India and China, while Japan is a leading market in the region. Water pollution has become a major crisis in China. An article published in Nature in June 2014 stated that over 200 million individuals fall ill due to acquisition of water borne diseases in China each year. Key players in the E.coli clinical testing market include Abbott Laboratories, Danaher Corporation, bioMerieux, Enzo Life Sciences, Inc., DiaSorin S.p.A., F.Roche Diagnostics, Thermo Fisher Scientific, Inc., Hologic, Becton, Dickinson and Company, and Bio-Rad Laboratories The global E.coli testing market has been segmented as below:  Global E.coli Testing Market, by Testing Methods  Environmental Testing Market, by Testing Methods  Membrane Filtration (MF) Transparency Market Research 3 E.coli Testing Market  Multiple Tube Fermentation (MTF)  Enzyme-Substrate Methods  Clinical Testing Market, by Testing Methods  Polymerase Chain Reaction (PCR) Tests  Enzyme Immunoassays (EIA)  Others  Global E.coli Testing Market, by End Users  Environmental  Home and Drinking Water Suppliers  Bottled Water Suppliers  Waste Water Treatment Organizations  Others (Government Agencies, Private Well Owners, Ground Water Testing, Farm Water Testing, etc.)  Clinical  Hospitals  Diagnostic Laboratories  Physician Offices  Global E.coli Testing Market, by Geography  North America  United States  Canada  Europe  Germany  United Kingdom  Rest of Europe  Asia Pacific Transparency Market Research 4 E.coli Testing Market  Japan  China  Rest of Asia Pacific  Latin America (LATAM)  Brazil  Mexico  Rest of LATAM  Africa  South Africa  Nigeria  Rest of Africa  Rest of the World (RoW) TABLE OF CONTENT Chapter 1 Preface 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology 1.3.1 Secondary Research 1.3.2 Primary Research 1.3.3 Assumptions Chapter 2 Executive Summary 2.1 Market Snapshot: Global E.coli Testing Market 2.2 Global Environmental E.coli Testing Market Revenue, 2013 (USD Million) Transparency Market Research 5 E.coli Testing Market Chapter 3 Market Overview 3.1 Overview 3.2 Market Drivers 3.2.1 High morbidity and rapid spread of E.coli augments market growth 3.2.2 Development of drug resistance species 3.2.3 Government initiatives boost demand for E.coli tests 3.3 Restraints 3.3.1 High cost of enzyme-substrate test as compared to separate apparatus 3.4 Opportunities 3.4.1 Polymerase chain reaction (PCR) based tests for environment water testing 3.5 Porter’s Five Forces Analysis: Global E.coli Testing Market 3.5.1 Bargaining power of suppliers 3.5.2 Bargaining power of buyers 3.5.3 Threat of substitutes 3.5.4 Threat of new entrants 3.5.5 Competitive rivalry 3.6 Market Attractiveness Analysis, by Geography, 2013 3.6.1 Market Attractiveness Analysis, by Geography, 2013 3.7 Heat Map Analysis: Global E.coli testing Market 3.7.1 Heat Map Analysis: Global E.coli Testing Market Chapter 4 Global E.coli Testing Market, by Testing Methods 4.1 Overview 4.2 Environmental Testing 4.2.1 Global Environmental Testing Market Revenue, by Types, 2012 – 2022 (USD Million) 4.2.2 Global Environmental Testing Market Volume, by Types, 2012 – 2022 (No.of Tests) (Million) Transparency Market Research 6 E.coli Testing Market 4.2.3 Membrane Filtration (MF) 4.2.3.1 Global Membrane Filtration Market Revenue, 2012 – 2022 (USD Million) 4.2.4 Multiple Tube Fermentation (MTF) 4.2.4.1 Global Multiple Tube Fermentation Market Revenue, 2012 – 2022 (USD Million) 4.2.5 Enzyme Substrate Methods 4.2.5.1 Global Enzyme Substrate Methods Market Revenue, 2012 – 2022 (USD Million) 4.3 Clinical Testing Methods 4.3.1 Global Clinical Testing Methods Market Revenue, by Types, 2012 – 2022 (USD Million) 4.3.2 Global Clinical Testing Methods Market Volume, by Types, 2012 – 2022 (No.of Tests) (Million) 4.3.3 Polymerase Chain Reaction (PCR) Tests 4.3.3.1 Global PCR Tests Market Revenue, 2012 – 2022 (USD Million) 4.3.4 Enzyme Immunoassays (EIA) 4.3.4.1 Global EIA Market Revenue, 2012 – 2022 (USD Million) 4.3.5 Others 4.3.5.1 Global Others Market Revenue, 2012 – 2022 (USD Million) Chapter 5 Global E.coli Testing Market, by End-User 5.1 Overview 5.2 Environmental Testing 5.2.1 Global Environmental Testing Market Revenue, by End-User, 2012 – 2022 (USD Million) 5.2.2 Global Environmental Testing Market Volume, by End-User, 2012 – 2022 (No.of Tests) (Million) 5.2.3 Home and Drinking Water Suppliers 5.2.3.1 Global Home and Drinking Water Suppliers Market Revenue, 2012 – 2022 (USD Million) 5.2.4 Bottled Water Suppliers 5.2.4.1 Global Bottled Water Suppliers Market Revenue, 2012 – 2022 (USD Million) 5.2.5 Waste Water Treatment Organizations 5.2.5.1 Global Waste Water Treatment Organizations Market Revenue, 2012 – 2022 (USD Million) Transparency Market Research 7 E.coli Testing Market 5.2.6 Others (Government Agencies, Private Well Owners, Ground Water Testing and Farm Water Testing) 5.2.6.1 Global Others Market Revenue, 2012 – 2022 (USD Million) 5.3 Clinical Testing 5.3.1 Global Clinical Testing Market Revenue, by End-User, 2012 – 2022 (USD Million) 5.3.2 Global Clinical Testing Market Volume, by End-User, 2012 – 2022 (No.of Tests)(Million) 5.3.3 Hospital 5.3.3.1 Global Hospital Market Revenue, 2012 – 2022 (USD Million) 5.3.4 Diagnostic Laboratories 5.3.4.1 Global Diagnostic Laboratories Market Revenue, 2012 – 2022 (USD Million) 5.3.5 Physician Offices 5.3.5.1 Global Physician Offices Market Revenue, 2012 – 2022 (USD Million) Chapter 6 Global E.coli Testing Market, by Geography 6.1 Overview 6.1.1 Global E.coli Testing Market Revenue, by Geography, 2012 – 2022 (USD Million) 6.1.2 Global E.coli Testing Market Volume, by Geography, 2012 – 2022 (No.of Tests) (Million) 6.2 North America 6.2.1 North America E.coli Testing Market Revenue, by Country, 2012 – 2022 (USD Million) 6.2.2 North America E.coli Testing Market Volume, by Country, 2012 – 2022 (No.of Tests) (USD Million) 6.3 Europe 6.3.1 Europe E.coli Testing Market Revenue, by Country, 2012 – 2022 (USD Million) 6.3.2 Europe E.coli Testing Market Volume, by Country, 2012 – 2022 (No.of Tests) (Million) 6.4 Asia Pacific 6.4.1 Asia Pacific E.coli Testing Market Revenue, by Country, 2012 – 2022 (USD Million) 6.4.2 Asia Pacific E.coli Testing Market Volume, by Country, 2012 – 2022 (No.of Tests) (Million) 6.5 Latin America 6.5.1 Latin America E.coli Testing Market Revenue, by Country, 2012 – 2022 (USD Million) Transparency Market Research 8 E.coli Testing Market 6.5.2 Latin America E.coli Testing Market Volume, by Country, 2012 – 2022 (No.of Tests) (Million) 6.6 Africa 6.6.1 Africa E.coli Testing Market Revenue, by Country, 2012 – 2022 (USD Million) 6.6.2 Africa E.coli Testing Market Volume, by Country, 2012 – 2022 (No.of Tests) (Million) 6.7 Rest of the World 6.7.1 RoW E.coli Testing Market Revenue, 2012 – 2022 (USD Million) 6.7.2 RoW E.coli Testing Market Volume, 2012 – 2022 (No.of Tests) (Million) Chapter 7 Recommendations 7.1 Development of low cost membrane filtration kit 7.2 Targeting private well water testing segment Chapter 8 Company Profiles 8.1 Abbott Laboratories 8.1.1 Company Overview 8.1.2 Financial Overview 8.1.3 Product Portfolio 8.1.4 Business Strategies 8.1.5 Recent Developments 8.2 Becton, Dickinson and Company 8.2.1 Company Overview 8.2.2 Financial Overview 8.2.3 Product portfolio 8.2.4 Business Strategies 8.2.5 Recent Developments 8.3 F.Hoffmann-La Roche Ltd. 8.3.1 Company Overview Transparency Market Research 9 E.coli Testing Market 8.3.2 Financial Overview 8.3.3 Product portfolio 8.3.4 Business Strategies 8.3.5 Recent Developments 8.4 Roka Bioscience, Inc. 8.4.1 Company overview 8.4.2 Financial Overview 8.4.3 Product Portfolio 8.4.4 Business Strategies 8.4.5 Building trust through product authorization 8.4.6 Recent Developments 8.5 Thermo Fisher Scientific, Inc. 8.5.1 Company Overview 8.5.2 Financial Overview 8.5.3 Product portfolio 8.5.4 Business Strategies 8.5.5 Recent Developments 8.6 Bio-Rad Laboratories, Inc. 8.6.1 Company Overview 8.6.2 Financial Overview 8.6.3 Product Portfolio 8.6.4 Business Strategies 8.6.5 Recent Developments 8.7 Danaher Corporation 8.7.1 Company Overview 8.7.2 Financial Overview 8.7.3 Product Portfolio Transparency Market Research 10 E.coli Testing Market 8.7.4 Business Strategies 8.7.5 Recent Developments 8.8 Meridian Bioscience, Inc. 8.8.1 Company Overview 8.8.2 Financial Overview 8.8.3 Product Portfolio 8.8.4 Business Strategies 8.8.5 Recent Developments 8.9 Pro Lab Diagnostics, Inc. 8.9.1 Company Overview 8.9.2 Financial Overview 8.9.3 Product Portfolio 8.9.4 Business Strategies 8.9.5 Recent Developments 8.10 IDEXX Laboratories, Inc. 8.10.1 Company Overview 8.10.2 Financial Overview 8.10.3 Product Portfolio 8.10.4 Business Strategies 8.10.5 Strategic acquisition 8.10.6 Recent Developments 8.11 Micrology Laboratories 8.11.1 Company Overview 8.11.2 Financial Overview 8.11.3 Product Portfolio 8.11.4 Business Strategies 8.11.5 Recent Developments Transparency Market Research 11 E.coli Testing Market 8.12 NanoLogix, Inc. 8.12.1 Company Overview 8.12.2 Financial Overview 8.12.3 Product Portfolio 8.12.4 Business Strategies 8.12.5 Recent Developments 8.13 Nelson Analytical Lab 8.13.1 Company Overview 8.13.2 Financial Overview 8.13.3 Product Portfolio 8.13.4 Business Strategies 8.13.5 Recent Developments 8.14 EMLab P&K, LLC 8.14.1 Company Overview 8.14.2 Financial Overview 8.14.3 Product Portfolio 8.14.4 Business Strategies 8.14.5 Recent Developments 8.15 CPI International, Inc. 8.15.1 Company Overview 8.15.2 Financial Overview 8.15.3 Product Portfolio 8.15.4 Business Strategies 8.15.5 Recent Developments 8.16 Ecolab, Inc. 8.16.1 Company Overview 8.16.2 Financial Overview Transparency Market Research 12 E.coli Testing Market 8.16.3 Product Portfolio 8.16.4 Business Strategies 8.16.5 Recent Developments Browse All Biotechnology Market Research Reports @ http://www.transparencymarketresearch.com/biotechnology-market-reports-18.html About Us Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge. Contact Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/ Transparency Market Research 13

According to a new market report published by Transparency Market Research “E.coli Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022,” the global E.coli testing market was valued at USD 1.2 billion in 2013 and is estimated to reach USD 2.1 billion by 2022 at a CAGR of 6.58% from 2014 to 2022. Browse the full report at http://www.transparencymarketresearch.com/e-coli-testing-market.html